641881099	641881099	CD	B-NP	O
|	|	NN	I-NP	O
NMC	NMC	NN	I-NP	O
|	|	NN	I-NP	O
16803216	16803216	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
9690801	9690801	CD	B-NP	O
|	|	CC	I-NP	O
10/10/2006	10/10/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CHF	CHF	NN	I-NP	I-protein
,	,	,	O	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/27/2006	2/27/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/6/2006	8/6/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
DORCENT	DORCENT	NNP	B-NP	O
,	,	,	O	O
DOMINGO	DOMINGO	NNP	B-NP	O
D	D	NNP	I-NP	O
856-99-02-2	856-99-02-2	CD	I-NP	O
Ence	Ence	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
RNM	RNM	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
10/7/06	10/7/06	CD	B-NP	O
AT	AT	NN	I-NP	O
01	01	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BIRCH	BIRCH	NNP	B-NP	O
,	,	,	O	O
RUBEN	RUBEN	NNP	B-NP	O
S.	S.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
325	325	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
8/19/06	8/19/06	CD	B-NP	O
by	by	IN	B-PP	O
ROB	ROB	NN	B-NP	B-protein
,	,	,	O	O
DERRICK	DERRICK	NNP	B-NP	O
K.	K.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
D.PHIL	D.PHIL	NNP	B-NP	O
.	.	.	O	O

on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
801439616	801439616	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
ALLOPURINOL	ALLOPURINOL	NN	I-NP	O
300	300	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
8/19/06	8/19/06	CD	B-NP	O
by	by	IN	B-PP	O
GIAMICHAEL	GIAMICHAEL	NNP	B-NP	O
,	,	,	O	O
FRED	FRED	NNP	B-NP	O
A.	A.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
D.PHIL	D.PHIL	NNP	B-NP	O
.	.	.	O	O

on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
801439616	801439616	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ALLOPURINOL	ALLOPURINOL	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
ATENOLOL	ATENOLOL	NN	I-NP	O
100	100	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
90	90	CD	B-NP	O
,	,	,	O	O
HR	HR	NN	B-NP	O
<	<	SYM	B-VP	O
50	50	CD	B-NP	O
CALCIUM	CALCIUM	NN	I-NP	O
CARBONATE	CARBONATE	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
500	500	CD	I-NP	O
MG	MG	NN	I-NP	O
ELEMENTAL	ELEMENTAL	NN	I-NP	O
CA	CA	NN	I-NP	O
+	+	SYM	B-VP	O
+	+	SYM	B-NP	O
-RRB-	-RRB-	SYM	O	O
500	500	CD	B-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
PEPCID	PEPCID	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
FAMOTIDINE	FAMOTIDINE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
COUMADIN	COUMADIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
6	6	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Standard	Standard	NNP	I-NP	O
Admin	Admin	NNP	I-NP	O
Time	Time	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/19/06	8/19/06	CD	B-NP	O
by	by	IN	B-PP	O
RAINBOTT	RAINBOTT	NNP	B-NP	O
,	,	,	O	O
QUINTIN	QUINTIN	NNP	B-NP	O
S.	S.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
D.PHIL	D.PHIL	NNP	B-NP	O
.	.	.	O	O

SERIOUS	SERIOUS	JJ	B-NP	O
INTERACTION	INTERACTION	NN	I-NP	O
:	:	:	O	O
ALLOPURINOL	ALLOPURINOL	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SULFAMETHOXAZOLE	SULFAMETHOXAZOLE	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
TACROLIMUS	TACROLIMUS	NN	I-NP	O
1	1	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Separate	Separate	JJ	I-NP	O
antacids	antacid	NNS	I-NP	O
by	by	IN	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
two	two	CD	I-NP	O
hours	hour	NNS	I-NP	O
and	and	CC	O	O
avoid	avoid	VB	B-VP	O
grapefruit	grapefruit	NN	B-NP	B-protein
juice	juice	NN	I-NP	I-protein
TACROLIMUS	TACROLIMUS	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QPM	QPM	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Separate	Separate	JJ	I-NP	O
antacids	antacid	NNS	I-NP	O
by	by	IN	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
two	two	CD	I-NP	O
hours	hour	NNS	I-NP	O
and	and	CC	O	O
avoid	avoid	VB	B-VP	O
grapefruit	grapefruit	NN	B-NP	B-protein
juice	juice	NN	I-NP	I-protein
BACTRIM	BACTRIM	NN	I-NP	I-protein
SS	SS	NN	I-NP	I-protein
-LRB-	-LRB-	SYM	B-NP	I-protein
TRIMETHOPRIM	TRIMETHOPRIM	NN	I-NP	I-protein
/	/	SYM	I-NP	I-protein
SULFAMETHOXAZOLE	SULFAMETHOXAZOLE	NN	I-NP	I-protein
SI	SI	NN	I-NP	I-protein
...	...	:	O	I-protein
-RRB-	-RRB-	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NNP	I-NP	O
Mon	Mon	NNP	I-NP	O
,	,	,	O	O
Wed	Wed	NNP	B-NP	O
,	,	,	O	O
Fri	Fri	NNP	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
8/19/06	8/19/06	CD	B-NP	O
by	by	IN	B-PP	O
WAKENIGHT	WAKENIGHT	NNP	B-NP	O
,	,	,	O	O
CLINT	CLINT	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
D.PHIL	D.PHIL	NNP	B-NP	O
.	.	.	O	O

on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
801439616	801439616	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SULFAMETHOXAZOLE	SULFAMETHOXAZOLE	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
CELLCEPT	CELLCEPT	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
MYCOPHENOLATE	MYCOPHENOLATE	NN	I-NP	O
MOFETIL	MOFETIL	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
500	500	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-SBAR	O
food	food	NN	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food	Food	NNP	I-NP	O
decreases	decrease	VBZ	B-VP	O
peak	peak	NN	B-NP	O
by	by	IN	B-PP	O
up	up	RB	B-NP	O
to	to	TO	I-NP	O
40	40	CD	I-NP	O
%	%	NN	I-NP	O
AMARYL	AMARYL	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
GLIMEPIRIDE	GLIMEPIRIDE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
4	4	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
90	90	CD	B-NP	O
PLAVIX	PLAVIX	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	O
-RRB-	-RRB-	HYPH	O	O
75	75	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
LANTUS	LANTUS	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
GLARGINE	GLARGINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
28	28	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
LASIX	LASIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
120	120	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
LIPITOR	LIPITOR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/7/06	10/7/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
NIFEREX-150	NIFEREX-150	NN	I-NP	O
150	150	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
LASIX	LASIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Other	Other	NNP	I-NP	O
:	:	:	O	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
prn	prn	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Fluid	Fluid	NN	B-NP	O
restriction	restriction	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
1800	1800	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Lupkes	Lupkes	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
cardiology	cardiology	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
3/8/06	3/8/06	CD	I-NP	O
11AM	11AM	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Brebes	Brebes	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
PCP	PCP	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
11/12/06	11/12/06	CD	I-NP	O
11	11	CD	I-NP	O
:	:	:	O	O
20	20	CD	B-NP	O
AM	AM	NN	I-NP	O
,	,	,	O	O
Sifers	Sifers	NNP	B-NP	O
,	,	,	O	O
Emmanuel	Emmanuel	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
nurse	nurse	NN	I-NP	O
with	with	IN	B-PP	O
CHF	CHF	NN	B-NP	O
patients	patient	NNS	I-NP	O
-RRB-	-RRB-	SYM	O	O
541-453-4501	541-453-4501	CD	B-NP	O
l70334	l70334	NN	I-NP	O
Within	Within	IN	B-PP	O
2	2	CD	B-NP	O
weeks	week	NNS	I-NP	O
at	at	IN	B-PP	O
your	your	PRP$	B-NP	O
convenience	convenience	NN	I-NP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
11/12/06	11/12/06	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
14	14	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Lundemo	Lundemo	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
:	:	:	O	O
Cephalosporins	Cephalosporin	NNS	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
CHF	CHF	NN	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CHF	CHF	NNP	I-NP	O
,	,	,	O	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
pain	pain	NN	I-NP	O
hypotension	hypotension	NN	I-NP	O
CAD	CAD	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CHF	CHF	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
diabetes	diabete	VBZ	B-VP	O
-LRB-	-LRB-	NN	B-NP	B-protein
diabetes	diabetes	NN	I-NP	I-protein
mellitus	mellitus	NN	I-NP	I-protein
type	type	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	I-protein
renal	renal	JJ	I-NP	I-protein
transplant	transplant	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
kidney	kidney	NN	I-NP	I-protein
transplant	transplant	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
AAA	AAA	NN	I-NP	I-protein
repair	repair	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	O
abdominal	abdominal	JJ	I-NP	O
aortic	aortic	JJ	I-NP	O
aneurysm	aneurysm	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
open	open	JJ	I-NP	O
chole	chole	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
cholelithiasis	cholelithiasis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
wt	wt	NN	B-NP	O
gain	gain	NN	I-NP	O
,	,	,	O	O
SOB	SOB	NN	B-NP	B-protein
:	:	:	O	O
CHF	CHF	NN	B-NP	B-DNA
flare	flare	NN	I-NP	I-DNA
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
HPI	HPI	NN	B-NP	O
:	:	:	O	O
72yo	72yo	CD	B-NP	O
M	M	NN	I-NP	O
unrelated	unrelated	JJ	I-NP	O
living	living	NN	I-NP	O
kidney	kidney	NN	I-NP	O
transplant	transplant	NN	I-NP	O
recipient	recipient	NN	I-NP	O
6/27	6/27	CD	I-NP	O
with	with	IN	B-PP	O
h/o	h/o	NN	B-NP	O
diastolic	diastolic	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
and	and	CC	O	O
multiple	multiple	JJ	B-NP	O
previous	previous	JJ	I-NP	O
admissions	admission	NNS	I-NP	O
for	for	IN	B-PP	O
CHF	CHF	NN	B-NP	B-DNA
flares	flare	NNS	I-NP	I-DNA
with	with	IN	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
manifested	manifest	VBN	B-VP	O
as	as	IN	B-PP	O
SOB	SOB	NN	B-NP	B-protein
and	and	CC	O	O
increased	increase	VBD	B-VP	O
weight	weight	NN	B-NP	O
and	and	CC	O	O
increased	increase	VBD	B-VP	O
LE	LE	NN	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
there	there	EX	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
some	some	DT	B-NP	O
concern	concern	NN	I-NP	O
that	that	IN	B-SBAR	O
patient	patient	NN	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
take	take	VB	I-VP	O
his	his	PRP$	B-NP	O
diuretics	diuretic	NNS	I-NP	O
as	as	IN	B-SBAR	O
prescribed	prescribe	VBN	B-VP	O
for	for	IN	B-PP	O
fear	fear	NN	B-NP	O
of	of	IN	B-PP	O
kidney	kidney	NN	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
now	now	RB	B-ADVP	O
states	state	VBZ	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
noted	note	VBN	I-VP	O
progressive	progressive	JJ	B-NP	O
SOB	SOB	NN	I-NP	B-protein
since	since	IN	B-PP	O
10/5	10/5	CD	B-NP	O
with	with	IN	B-PP	O
marked	mark	VBN	B-NP	O
increased	increase	VBD	B-VP	O
in	in	IN	B-PP	O
SOB	SOB	NN	B-NP	B-protein
,	,	,	O	O
DOE	DOE	NN	B-NP	O
and	and	CC	O	O
orthopnea	orthopnea	NN	B-NP	O
over	over	IN	B-PP	O
304	304	CD	B-NP	O
days	day	NNS	I-NP	O
PTA	PTA	NN	I-NP	B-protein
.	.	.	O	O

Pt	Pt	NN	B-NP	O
is	be	VBZ	B-VP	O
currently	currently	RB	B-ADJP	O
unable	unable	JJ	I-ADJP	O
to	to	TO	B-VP	O
walk	walk	VB	I-VP	O
more	more	JJR	B-NP	O
than	than	IN	B-PP	O
approximately	approximately	RB	B-ADVP	O
20	20	CD	B-NP	O
feet	foot	NNS	I-NP	O
without	without	IN	B-PP	O
becoming	become	VBG	B-VP	O
significantly	significantly	RB	B-ADJP	O
dyspnic	dyspnic	JJ	I-ADJP	O
,	,	,	O	O
having	have	VBG	B-VP	O
to	to	TO	I-VP	O
sit	sit	VB	I-VP	O
and	and	CC	I-VP	O
take	take	VB	I-VP	O
deep	deep	JJ	B-NP	O
breaths	breath	NNS	I-NP	O
for	for	IN	B-PP	O
5-10	5-10	CD	B-NP	O
minutes	minute	NNS	I-NP	O
to	to	TO	B-VP	O
``	``	``	O	O
catch	catch	VB	B-VP	O
his	his	PRP$	B-NP	O
breath	breath	NN	I-NP	O
.	.	.	O	O
''	''	''	O	O

Pt	Pt	NN	B-NP	O
sleeps	sleep	NNS	I-NP	O
on	on	IN	B-PP	O
1	1	CD	B-NP	O
pillow	pillow	NN	I-NP	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
changed	change	VBN	I-VP	O
.	.	.	O	O

Denies	Deny	NNS	B-NP	O
PND	PND	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
also	also	RB	B-ADVP	O
notes	note	VBZ	B-VP	O
increased	increase	VBN	B-NP	O
abd	abd	NN	I-NP	O
girth	girth	NN	I-NP	O
and	and	CC	O	O
bl	bl	NN	B-NP	O
LE	LE	NN	I-NP	O
swelling	swelling	NN	I-NP	O
.	.	.	O	O

Gained	Gain	VBN	B-VP	O
18-20lb	18-20lb	JJ	B-ADJP	O
over	over	IN	B-PP	O
last	last	JJ	B-NP	O
6months	6month	NNS	I-NP	O
PTA	PTA	NN	I-NP	B-protein
.	.	.	O	O

Pt	Pt	NN	B-NP	O
took	take	VBD	B-VP	O
80mg	80mg	CD	B-NP	O
po	po	NN	I-NP	O
tid	tid	VBD	B-VP	O
up	up	RB	B-ADVP	O
from	from	IN	B-PP	O
80mg	80mg	CD	B-NP	O
po	po	NN	I-NP	O
bid	bid	NN	I-NP	O
lasix	lasix	NN	I-NP	O
over	over	IN	B-PP	O
3d	3d	JJ	B-NP	O
PTA	PTA	NN	I-NP	O
with	with	IN	B-PP	O
respective	respective	JJ	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
urine	urine	NN	B-NP	O
output	output	NN	I-NP	O
.	.	.	O	O

ROS	ROS	NN	B-NP	O
:	:	:	O	O
+	+	SYM	B-NP	O
chronic	chronic	JJ	I-NP	O
intermittent	intermittent	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
for	for	IN	B-PP	O
many	many	JJ	B-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
described	describe	VBN	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
``	``	``	I-NP	O
pressure	pressure	NN	I-NP	O
,	,	,	O	O
''	''	''	O	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
focal	focal	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
migratory	migratory	JJ	I-ADJP	O
throughout	throughout	IN	B-PP	O
abd	abd	NN	B-NP	O
and	and	CC	B-PP	O
around	around	IN	B-PP	O
anterior	anterior	JJ	B-NP	O
chest	chest	NN	I-NP	O
-	-	HYPH	B-VP	O
no	no	DT	B-NP	O
increase	increase	NN	I-NP	O
or	or	CC	I-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
recently	recently	RB	B-ADVP	O
or	or	CC	O	O
with	with	IN	B-PP	O
exertion	exertion	NN	B-NP	O
.	.	.	O	O

+	+	SYM	O	O
``	``	``	B-NP	O
productive	productive	JJ	I-NP	O
''	''	''	I-NP	O
cough	cough	NN	I-NP	O
x2-3	x2-3	NN	I-NP	O
days	day	NNS	I-NP	O
PTA	PTA	NN	I-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
blood	blood	NN	I-NP	O
-	-	HYPH	B-ADJP	O
but	but	CC	O	O
pt	pt	NN	B-NP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
say	say	VB	I-VP	O
what	what	WP	B-NP	O
color	color	NN	I-NP	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
productive	productive	JJ	B-ADJP	O
of	of	IN	B-PP	O
as	as	IN	B-SBAR	O
he	he	PRP	B-NP	O
does	do	VBZ	B-VP	O
``	``	``	O	O
not	not	RB	O	O
look	look	VB	B-VP	O
at	at	IN	B-PP	O
it	it	PRP	B-NP	O
.	.	.	O	O
''	''	''	O	O

Pt	Pt	NN	B-NP	O
also	also	RB	B-ADVP	O
complains	complain	VBZ	B-VP	O
of	of	IN	B-PP	O
slight	slight	JJ	B-NP	O
asymmetric	asymmetric	JJ	I-NP	O
swelling	swelling	NN	I-NP	O
of	of	IN	B-PP	O
LE	LE	NNP	B-NP	O
L	L	NNP	I-NP	O
>	>	NNP	I-NP	O
R.	R.	NNP	I-NP	O
+	+	CC	O	O
mild	mild	JJ	B-NP	O
diffuse	diffuse	JJ	I-NP	O
abd	abd	NN	I-NP	O
pain	pain	NN	I-NP	O
''	''	''	O	O
when	when	WRB	B-ADVP	O
I	I	PRP	B-NP	O
push	push	VBP	B-VP	O
on	on	IN	B-PP	O
it	it	PRP	B-NP	O
,	,	,	O	O
''	''	''	O	O
which	which	WDT	B-NP	O
pt	pt	VBP	B-VP	O
states	state	NNS	B-NP	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
only	only	RB	I-VP	O
noticed	notice	VBN	I-VP	O
over	over	IN	B-PP	O
few	few	JJ	B-NP	O
days	day	NNS	I-NP	O
PTA.No	PTA.No	NN	I-NP	O
Fevers	Fever	NNS	I-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
NS	NS	NN	B-NP	O
,	,	,	O	O
change	change	NN	B-NP	O
in	in	IN	B-PP	O
BMs	BM	NNS	B-NP	B-cell_type
-LRB-	-LRB-	SYM	O	O
2	2	CD	B-NP	O
nl	nl	NN	I-NP	O
,	,	,	O	O
brown	brown	VBN	B-VP	O
BMs/day	BMs/day	NNP	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
blood	blood	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
constipation	constipation	NN	I-NP	O
,	,	,	O	O
H/A	H/A	NN	B-NP	O
,	,	,	O	O
L/H	L/H	NN	B-NP	O
,	,	,	O	O
change	change	NN	B-NP	O
in	in	IN	B-PP	O
eye	eye	NN	B-NP	O
or	or	CC	I-NP	O
ear	ear	NN	I-NP	O
function	function	NN	I-NP	O
recently	recently	RB	B-ADVP	O
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	:	O	O
PMH	PMH	NN	B-NP	O
:	:	:	O	O
CAD	CAD	NN	B-NP	O
,	,	,	O	O
ppm	ppm	NN	B-NP	O
for	for	IN	B-PP	O
SSS	SSS	NN	B-NP	B-protein
,	,	,	O	O
DMII	DMII	NN	B-NP	B-protein
,	,	,	O	O
OSA	OSA	NN	B-NP	B-protein
,	,	,	O	O
CPAP	CPAP	NN	B-NP	B-protein
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
gout	gout	NN	B-NP	O
,	,	,	O	O
AAA	AAA	NN	B-NP	O
repair	repair	NN	I-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
choly	choly	NN	I-NP	O
ALLERGIES	ALLERGIES	NN	I-NP	O
:	:	:	O	O
NKDA	NKDA	NN	B-NP	B-protein
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	B-NP	O
PE	PE	NN	I-NP	O
VS	VS	NN	I-NP	O
:	:	:	O	O
T97	T97	NN	B-NP	O
.0	.0	CD	I-NP	O
P	P	NN	I-NP	O
:	:	:	O	O
70	70	CD	B-NP	O
BP	BP	NN	I-NP	O
:	:	:	O	O
140	140	CD	B-NP	O
/	/	SYM	I-NP	O
78	78	CD	I-NP	O
RR	RR	NN	I-NP	O
:	:	:	O	O
15	15	CD	B-NP	O
O2	O2	NN	I-NP	O
Sat	Sat	NNP	I-NP	O
:	:	:	O	O
98	98	CD	B-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
Gen	Gen	NNP	I-NP	O
Mild	Mild	NNP	I-NP	O
respiratory	respiratory	JJ	I-NP	O
distress	distress	NN	I-NP	O
after	after	IN	B-PP	O
walking	walk	VBG	B-VP	O
to	to	TO	B-PP	O
BR	BR	NN	B-NP	B-protein
.	.	.	O	O

Conversant	Conversant	JJ	B-ADJP	O
.	.	.	O	O

HEENT	HEENT	NNP	B-NP	O
Sclerae	Sclerae	NNP	I-NP	O
anicteric	anicteric	NN	I-NP	O
.	.	.	O	O

PERRL	PERRL	NN	B-NP	B-protein
.	.	.	O	O

EOMI	EOMI	LS	B-LST	B-DNA
.	.	.	O	O

Oropharynx	Oropharynx	NN	B-NP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

Gums	Gum	NNS	B-NP	O
,	,	,	O	O
lips	lip	NNS	B-NP	O
,	,	,	O	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
supraclavicular	supraclavicular	JJ	I-NP	O
or	or	CC	I-NP	O
cervical	cervical	JJ	I-NP	O
LAD	LAD	NN	I-NP	O
.	.	.	O	O

Thyroid	Thyroid	JJ	B-NP	O
nontender	nontender	NN	I-NP	O
and	and	CC	I-NP	O
w/o	w/o	NN	I-NP	O
nodules	nodule	NNS	I-NP	O
.	.	.	O	O

JVP	JVP	NN	B-NP	O
=	=	SYM	B-VP	O
15cmCV	15cmCV	NN	B-NP	O
Distant	Distant	JJ	I-NP	O
heart	heart	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
rubs	rub	NNS	I-NP	O
or	or	CC	I-NP	O
gallops	gallop	NNS	I-NP	O
appreciated.Pulm	appreciated.Pulm	NN	I-NP	O
:	:	:	O	O
Mild	Mild	NNP	B-NP	O
end	end	VBP	B-VP	O
expiratory	expiratory	JJ	B-NP	O
wheezing	wheezing	NN	I-NP	O
throughout	throughout	IN	B-PP	O
with	with	IN	B-PP	O
slight	slight	JJ	B-NP	O
decreased	decrease	VBN	I-NP	O
BS	BS	NN	I-NP	O
at	at	IN	B-PP	O
R	R	NN	B-NP	B-protein
base	base	NN	I-NP	I-protein
.	.	.	O	O

Symmetric	Symmetric	JJ	B-NP	O
&	&	CC	I-NP	O
clear	clear	JJ	I-NP	O
percussion	percussion	NN	I-NP	O
throughout	throughout	IN	B-ADVP	O
.	.	.	O	O

Abd	Abd	NN	B-NP	B-protein
+	+	SYM	I-NP	O
BS	BS	NNP	I-NP	O
.	.	.	O	O

Nontender	Nontender	NNP	B-NP	O
.	.	.	O	O

Obese	Obese	UH	B-INTJ	O
.	.	.	O	O

Nondistended	Nondistende	VBN	B-VP	O
.	.	.	O	O

No	No	DT	B-NP	O
clear	clear	JJ	I-NP	O
ascites	ascite	NNS	I-NP	O
on	on	IN	B-PP	O
percussion	percussion	NN	B-NP	O
.	.	.	O	O

Ext/Skin	Ext/Skin	NNP	B-NP	O
WWP	WWP	NNP	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
+	+	SYM	I-NP	O
Bl	Bl	NN	I-NP	O
LE	LE	NN	I-NP	O
pitting	pit	VBG	B-VP	O
edema	edema	NN	B-NP	O
to	to	TO	B-PP	O
mid	mid	JJ	B-NP	O
shin	shin	NN	I-NP	O
,	,	,	O	O
L	L	NN	B-NP	O
slightly	slightly	RB	B-NP	O
>	>	JJR	I-NP	O
R.	R.	NNP	I-NP	O
Pulses	Pulses	NNP	I-NP	O
sym	sym	NN	I-NP	O
and	and	CC	O	O
full	full	JJ	B-ADJP	O
at	at	IN	B-PP	O
radial	radial	NN	B-NP	O
and	and	CC	I-NP	O
dorsalis	dorsalis	NN	I-NP	O
pedis	pedis	NN	I-NP	O
pulses	pulse	NNS	I-NP	O
BL	BL	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
rashes	rash	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
Calf	Calf	NN	I-NP	B-protein
or	or	CC	I-NP	O
leg	leg	NN	I-NP	O
tenderness	tenderness	NN	I-NP	O
BL	BL	NN	I-NP	O
.	.	.	O	O

Neuro	Neuro	NN	B-NP	B-protein
A+O	A+O	NN	I-NP	I-protein
x3	x3	NN	I-NP	I-protein
.	.	.	O	O

Follows	Follow	VBZ	B-VP	O
complex	complex	JJ	B-NP	O
commands	command	NNS	I-NP	O
.	.	.	O	O

CN	CN	NN	B-NP	O
2-12	2-12	CD	I-NP	O
symmetric	symmetric	JJ	I-NP	O
&	&	CC	I-NP	O
intact	intact	JJ	I-NP	O
.	.	.	O	O

Strength	Strength	NN	B-NP	O
5/5	5/5	CD	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
in	in	IN	B-PP	O
UE	UE	NN	B-NP	O
and	and	CC	I-NP	O
LE	LE	NN	I-NP	O
.	.	.	O	O

Conversant	Conversant	JJ	B-NP	O
&	&	CC	I-NP	O
appropriate	appropriate	JJ	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
pronator	pronator	NN	I-NP	O
drift	drift	NN	I-NP	O
.	.	.	O	O

Normal	Normal	JJ	B-NP	O
finger-to-nose	finger-to-nose	NN	I-NP	O
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
ASSESSMENT	ASSESSMENT	NN	B-NP	O
:	:	:	O	O
72yo	72yo	CD	B-NP	O
M	M	NN	I-NP	O
kidney	kidney	NN	I-NP	O
transplant	transplant	NN	I-NP	O
recipient	recipient	NN	I-NP	O
on	on	IN	B-PP	O
immunomodulatory	immunomodulatory	JJ	B-NP	O
medications	medication	NNS	I-NP	O
per	per	IN	B-PP	O
protocol	protocol	NN	B-NP	O
with	with	IN	B-PP	O
h/o	h/o	NN	B-NP	B-protein
diastolic	diastolic	JJ	I-NP	I-protein
CHF	CHF	NN	I-NP	I-protein
presents	present	VBZ	B-VP	O
w	w	NN	B-NP	O
/	/	SYM	I-NP	O
progressive	progressive	JJ	I-NP	O
SOB	SOB	NN	I-NP	O
,	,	,	I-NP	O
DOE	DOE	NN	I-NP	O
and	and	CC	I-NP	O
wt	wt	NN	I-NP	O
gain	gain	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
and	and	CC	O	O
another	another	DT	B-NP	O
CHF	CHF	NN	I-NP	B-DNA
flare	flare	NN	I-NP	I-DNA
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
-	-	HYPH	B-NP	O
Ischemia	Ischemia	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
acute	acute	JJ	I-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

Continue	Continue	JJ	B-NP	O
home	home	NN	I-NP	O
ASA	ASA	NN	I-NP	O
,	,	,	O	O
palvix	palvix	NN	B-NP	O
,	,	,	O	O
statin	statin	NN	B-NP	O
,	,	,	O	O
BB	BB	NNP	B-NP	O
-	-	HYPH	I-NP	O
Pump	Pump	NNP	I-NP	O
:	:	:	O	O
h/o	h/o	VB	B-VP	O
diastolic	diastolic	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
.	.	.	O	O

volume	volume	NN	B-NP	O
overloaded	overload	VBD	B-VP	O
at	at	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Increased	Increase	VBN	B-NP	O
home	home	NN	I-NP	O
lasix	lasix	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
80mg	80mg	NN	B-NP	O
po	po	NN	I-NP	O
bid	bid	NN	I-NP	O
to	to	TO	B-PP	O
80mg	80mg	CD	B-NP	O
iv	iv	JJ	I-NP	O
tid	tid	NN	I-NP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
patient	patient	NN	B-NP	O
.	.	.	O	O

he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
about	about	IN	B-PP	O
2L	2L	NN	B-NP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
weight	weight	NN	I-NP	O
decreased	decrease	VBD	B-VP	O
from	from	IN	B-PP	O
225	225	CD	B-NP	O
to	to	TO	B-PP	O
216	216	CD	B-NP	O
at	at	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
close	close	JJ	B-ADJP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
euvolemic	euvolemic	JJ	I-NP	O
state	state	NN	I-NP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
JVP	JVP	NN	I-NP	B-protein
decreasing	decrease	VBG	B-VP	O
from	from	IN	B-PP	O
15cm	15cm	NN	B-NP	O
at	at	IN	B-PP	O
admission	admission	NN	B-NP	O
to	to	TO	B-VP	O
6cm	6cm	VB	I-VP	O
at	at	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
discharged	discharge	VBD	B-VP	O
on	on	IN	B-PP	O
120mg	120mg	NN	B-NP	O
po	po	NN	I-NP	O
bid	bid	NN	I-NP	O
+	+	SYM	B-NP	O
80mg	80mg	NN	I-NP	O
po	po	NN	I-NP	O
qd	qd	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
set	set	VBN	I-VP	O
up	up	RP	B-PRT	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
assistance	assistance	NN	B-NP	O
from	from	IN	B-PP	O
Walthers	Walthers	NNP	B-NP	O
,	,	,	O	O
Roderick	Roderick	NNP	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
CHF	CHF	NN	I-NP	O
service	service	NN	I-NP	O
to	to	TO	B-VP	O
assist	assist	VB	I-VP	O
w	w	NN	B-NP	O
/	/	SYM	B-PP	O
following	follow	VBG	B-PP	O
his	his	PRP$	B-NP	O
daily	daily	JJ	I-NP	O
weights	weight	NNS	I-NP	O
and	and	CC	I-NP	O
lasix	lasix	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
f/u	f/u	VB	I-VP	O
with	with	IN	B-PP	O
her	her	PRP	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
his	his	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
within2	within2	NN	I-NP	O
weeks	week	NNS	I-NP	O
of	of	IN	B-PP	O
discharge.Continue	discharge.Continue	NN	B-NP	B-protein
BB	BB	NN	I-NP	I-protein
.	.	.	O	O

-	-	HYPH	B-NP	O
R	R	NNP	I-NP	O
&	&	CC	I-NP	O
R	R	NNP	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
without	without	IN	B-PP	O
event	event	NN	B-NP	O
throughout	throughout	IN	B-PP	O
hospital	hospital	NN	B-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

Continue	Continue	JJ	B-NP	O
home	home	NN	I-NP	O
coumadin	coumadin	NN	I-NP	O
,	,	,	O	O
currently	currently	RB	B-ADJP	O
therapeutic	therapeutic	JJ	I-ADJP	O
with	with	IN	B-PP	O
goal	goal	NN	B-NP	O
INR	INR	NN	I-NP	O
2-3	2-3	NN	I-NP	O
.	.	.	O	O

--	--	:	O	O
ID	ID	NN	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
current	current	JJ	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

--	--	:	O	O
RENAL	RENAL	NN	B-NP	O
:	:	:	O	O
Cre	Cre	VB	B-VP	O
currently	currently	RB	B-ADVP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
of	of	IN	B-PP	O
about	about	RB	B-NP	O
1.7	1.7	CD	I-NP	O
s/p	s/p	NN	I-NP	O
kidney	kidney	NN	I-NP	O
transplant	transplant	NN	I-NP	O
approx	approx	NN	I-NP	O
2y	2y	NN	I-NP	O
PTA	PTA	NN	I-NP	O
.	.	.	O	O

Continue	Continue	JJ	B-NP	O
immunosuppressants	immunosuppressant	NNS	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
dosing	dosing	NN	I-NP	O
.	.	.	O	O

Continue	Continue	JJ	B-NP	O
bactrim	bactrim	JJ	I-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
--	--	:	O	O
PULM	PULM	NN	B-NP	O
:	:	:	O	O
Given	Give	VBN	B-VP	O
mild	mild	JJ	B-NP	O
wheezing	wheezing	NN	I-NP	O
on	on	IN	B-PP	O
exam	exam	NN	B-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
given	give	VBN	B-VP	O
Duonebs	Duoneb	NNS	B-NP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
patient	patient	NN	B-NP	O
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
improvement	improvement	NN	I-NP	O
in	in	IN	B-PP	O
SOB	SOB	NN	B-NP	B-protein
.	.	.	O	O

--	--	:	O	O
HEME	HEME	NN	B-NP	B-protein
:	:	:	O	O
Baseline	Baseline	NN	B-NP	O
HCT	HCT	NN	I-NP	O
38-41	38-41	CD	I-NP	O
Continue	Continue	NNP	I-NP	O
home	home	NN	I-NP	O
iron	iron	NN	I-NP	O
replacement	replacement	NN	I-NP	O
--	--	:	O	O
FEN	FEN	NN	B-NP	O
:	:	:	O	O
Electrolytes	Electrolyte	NNS	B-NP	O
were	be	VBD	B-VP	O
replaced	replace	VBN	I-VP	O
prn	prn	NN	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Mg	Mg	NNP	I-NP	O
and	and	CC	O	O
K	K	NNP	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
tolerated	tolerate	VBD	B-VP	O
an	an	DT	B-NP	O
ADA	ADA	NNP	I-NP	O
,	,	,	O	O
Low	Low	NNP	B-NP	O
Na	Na	NNP	I-NP	O
,	,	,	O	O
1.5	1.5	CD	B-NP	O
L	L	NN	I-NP	O
fluid	fluid	NN	I-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
fat	fat	NN	I-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

--	--	:	O	O
ENDO	ENDO	NN	B-NP	O
:	:	:	O	O
nl	nl	NN	B-NP	O
TSH	TSH	NN	I-NP	O
8/2	8/2	CD	B-NP	O
and	and	CC	O	O
now	now	RB	B-ADVP	O
=	=	SYM	B-VP	O
2.136	2.136	CD	B-NP	O
.	.	.	O	O

Contiued	Contiue	VBN	B-NP	O
home	home	NN	I-NP	O
amaryl	amaryl	NN	I-NP	O
,	,	,	O	O
lantus	lantus	NN	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
have	have	VB	I-VP	O
diabetes	diabetes	NN	B-NP	O
followed	follow	VBN	B-VP	O
closely	closely	RB	B-ADVP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpaient	outpaient	NN	I-NP	O
.	.	.	O	O

--	--	:	O	O
NEURO	NEURO	NN	B-NP	B-protein
:	:	:	O	O
Ambien	Ambien	JJ	B-NP	O
given	give	VBN	I-NP	O
prn	prn	NN	I-NP	O
.	.	.	O	O

--	--	:	O	O
PPX	PPX	NN	B-NP	B-protein
:	:	:	O	O
Continued	Continue	VBN	B-NP	O
home	home	NN	I-NP	O
bactrim	bactrim	NN	I-NP	O
and	and	CC	I-NP	O
allopurinol	allopurinol	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
therapeutic	therapeutic	JJ	B-ADJP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
.	.	.	O	O

PPI	PPI	NNP	B-NP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
and	and	CC	O	O
senna	senna	NN	B-NP	O
given	give	VBN	B-VP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
patient	patient	NN	B-NP	O
.	.	.	O	O

Encouarged	Encouarged	JJ	B-NP	O
ambulation	ambulation	NN	I-NP	O
.	.	.	O	O

--	--	:	O	O
CODE	CODE	NN	B-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
ADDITIONAL	ADDITIONAL	JJ	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Take	Take	VB	B-VP	O
all	all	DT	B-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
directed	direct	VBN	B-VP	O
and	and	CC	O	O
follow	follow	VB	B-VP	O
your	your	PRP$	B-NP	O
daily	daily	JJ	I-NP	O
weights	weight	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
Follow	Follow	VB	B-VP	O
your	your	PRP$	B-NP	O
daily	daily	JJ	I-NP	O
weights	weight	NNS	I-NP	O
and	and	CC	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
lasix	lasix	NN	B-NP	O
taken	take	VBN	B-VP	O
.	.	.	O	O

Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
closely	closely	RB	B-ADVP	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
and	and	CC	I-NP	O
nephrologist	nephrologist	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
.	.	.	O	O

Call	Call	VB	B-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
any	any	DT	B-NP	O
questions	question	NNS	I-NP	O
or	or	CC	I-NP	O
concerns	concern	NNS	I-NP	O
or	or	CC	O	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
develop	develop	VBP	B-VP	O
any	any	DT	B-NP	O
concerning	concern	VBG	I-NP	O
symptoms	symptom	NNS	I-NP	O
including	include	VBG	B-PP	O
any	any	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
difficulty	difficulty	NN	B-NP	O
breathing	breathing	NN	I-NP	O
or	or	CC	I-NP	O
fever	fever	NN	I-NP	O
.	.	.	O	O

Call	Call	VB	B-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
for	for	IN	B-PP	O
weight	weight	NN	B-NP	O
gain	gain	NN	I-NP	O
of	of	IN	B-PP	O
more	more	JJR	B-NP	O
than	than	IN	B-PP	O
2lb	2lb	NN	B-NP	B-protein
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
EARLS	EARLS	NNS	B-NP	B-protein
,	,	,	O	O
RANDELL	RANDELL	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
D.PHIL	D.PHIL	NNP	B-NP	O
.	.	.	O	O

-LRB-	-LRB-	HYPH	B-NP	O
YJ55	YJ55	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	O
10/7/06	10/7/06	CD	I-NP	O
@	@	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
05	05	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

